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This paper examines the occurrence of European Works Councils (EWCs) in the healthcare sector through a 
review of multinational companies involved in the healthcare sector.  The paper starts with an outline of 
European Works Councils in EU legislation, followed by public health and healthcare policy in Europe.  
This is followed by an overview of issues facing multinational companies involved in the healthcare sector.  
A series of short company profiles follows which includes a) companies eligible for EWCs, b) companies 
which will become eligible after accession in 2004 and c) companies not yet eligible for EWCs. 
1 European Works Councils and EU legislation  
 
The European Works Councils (EWC) Directive, initially adopted in 19941, aims to improve the right of 
workers to information and consultation in trans-national companies. It requires transnational companies to 
establish information and consultation agreements covering their entire European workforce, if they have not 
already done so. The content of these agreements is largely left to negotiation between management and 
employee representatives, but minimum requirements where management refuses to negotiate include the 
requirement of annual reports to the EWC on the company‟s business prospects, and the right to be informed 
about exceptional circumstances affecting employees‟ interests, such as closure or collective redundancy.  
 
The EWC directive applies to companies,2 or groups of companies3, with  
 
 at least 10004 employees across the member states5, and 
                                                     
1
 Directive 94/45/EC was adopted by all EU member states except the UK on 22 September 1994, under Article 2(2) of 
the Agreement on Social Policy (the "Social Chapter") and was later extended to cover the rest of the European 
Economic Area (Norway, Liechtenstein and Iceland). The deadline for national implementation in these member states 
was 22 September 1996. The original Directive was extended to cover the UK by directive 97/74/EC in December 
1997. 
2 Strictly speaking, the requirements apply to “undertakings”, a term which may include partnerships or other forms of 
organisation as well as companies. http://www.dti.gov.uk/er/consultation/ewcover2.htm 
3 A group of companies (undertakings) includes a controlling company and any companies it controls (“exerts a 
dominant influence over”), whether by virtue of ownership, financial participation or the governing rules of the 
controlled company. 
4 Based on the average number of employees, including part-time employees, employed during the previous two years 
calculated according to national legislation and/or practice. http://europa.eu.int/comm/employment_social/soc-
dial/labour/directive9445/9445euen.htm 
5 “Member states” means the member states of the European Union, but for the purposes of the EWC Directive includes 
since 1996 the rest of the European Economic Area (Norway, Liechtenstein and Iceland). The UK opted out of the 
EWC directive until December 1997. From 1995 to 2003 the EU had 15 members (Austria, Belgium, Denmark, 
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 at least 150 employees in each of two or more distinct member states. 
 
These employment criteria represent a lower bound – companies meeting them are obliged to establish an 
EWC, but companies which do not meet them may nonetheless choose to establish one voluntarily. In a 
number of instances companies have chosen to do so, whether it be for purposes of labour relations, prestige 
(to demonstrate Europe-wide coverage), or (in the case of UK during its opt out) in the expectation of the 
future introduction of a legal obligation. 
 
2 Health policy in Europe 
2.1 Historical background  
 
Historically health competences at EU level have been developed to promote a common market.  Other 
aspects of health policy have evolved as a result of policy developments in related fields.  Health policy has 
traditionally been caught between the EU Treaties implemented through European legislation and the 
European Court of Justice (ECJ), and policy making which has been consensual between member states.  
Recently, the ECJ has had an influence on health policy in the fields of health care, medicines, environment, 
workplace health and safety and pharmaceuticals/ distribution.  Health care has been most strongly 
influenced by the concept of subsidiarity with national governments considering national health care systems 
to be their own responsibility.   
 
The Single European Act of 1986 established an extension of the Community actions in relation to health 
although health policy was not treated as a separate policy area.  It did extend the scope of occupational 
health and safety, and environmental and consumer protection. 6 
 
The Treaty of European Union (Maastricht Treaty) of 1992 amended the Treaty of Rome with a 
formalisation of the powers relating to health care. Article 3(o)  “contributes to the attainments of a high 
level of health protection”. Article 129 dealt with public health and the prevention of disease and provided a 
framework for working towards health protection.   Article 3(b) established the principle of subsidiarity 
especially in relation to health care, which has effectively limited the Community‟s role in health.  
   
The Treaty of Amsterdam resulting from the Intergovernmental Conference of 1997 and finally ratified in 
1999 has a specific Article 152 relating to public health. 7  It states  
“Community action, which shall complement national policies, shall be directed towards improving 
public health, preventing human illness and diseases, and obviating scourges of danger to human 
health”.   
It also states  
“Community action in the field of public health shall fully respect the responsibilities of the Member 
States for the organisation and delivery of health services and medical care”.   
There was also a reassertion of the subsidiarity principle in relation to health care systems. 
 
As a result of agreeing Article 152, a new Directorate was set up for Health and Consumer Affairs, which 
drafts proposals for legislation.  The European Parliament deals with health issues through the Committee for 
Environment, Public Health and Consumer Protection.  Health policy actually cuts across all directives and 
there is no coherent health policy strategy. 
 
                                                                                                                                                                                
Finland, France, Germany, Greece, Ireland, Italy, Luxemburg, Netherlands, Portugal, Spain, Sweden, UK), with 10 
more countries expected to join in 2004. 
6 Article 129 Maastricht Treaty http://europa.eu.int/en/record/mt/title2.html 
7 Article 152 Amsterdam Treaty  http://europa.eu.int/scadplus/leg/en/lvb/a16000.htm#a16003.   
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2.2 Healthcare and competition policy 
 
One of the major issues facing national healthcare systems is whether healthcare institutions are subject to 
competition law.  The key question is whether they engage in economic activity.  Each activity has to be 
judged on its merits.  However, the results of health care reforms often mean that with the introduction of 
market mechanisms and decentralisation, healthcare institutions are more vulnerable to being considered 
subject to competition law.   
 
Subsidiarity has been an important principle for European health services but the impact of several EU 
Directives e.g. movement of professionals, insurance, is beginning to influence national health systems 
directly.  Several rulings by the European Court of Justice have made national governments aware of the 
implications of greater consumer choice.  If this is combined with the effect of increasing demand for 
healthcare services, often seen through increased waiting lists, then cross-border health care is likely to 
increase in the future.  EU competition policy is also beginning to affect healthcare systems that have 
introduced business approaches and techniques and so can be less obviously defined as services of “general 
interest”.  
 
2.3 Internal market for services 
 
In January 2004 the European Commission presented a Directive Proposal on services in the internal market, 
which aims to provide a legal framework to eliminate obstacles for the establishment of service providers 
and barriers to the free movement of services.8  This has several implications for the healthcare sector.  
Positively, it is expected to improve access to outpatient care because of simplifying the process of 
reimbursement of healthcare delivered to a patient in another Member state although some measures will  
have to be taken to avoid disparities between healthcare systems in certain countries.  
 
In relation to the posting of workers, Member state governments will have limited scope to influence the 
labour standards of workers who are employed in their country by a company from another country.  The 
proposal is for the government of the country of origin of the company to try and influence labour standards 
and legislation because “a provider must, as a general rule, only be subject to the law of the country within 
which it is established”.  This will limit the power of governments to take action against undocumented 
migrant workers if they are recruited by an agency based in another EU country.  This may have implications 
for the recruitment of health and social care workers.   
 
Perhaps the most complex issues for the healthcare sector relate to the registration of professionals.  The aim 
of the Directive Proposal  is to simplify the barriers to service providers being able to operate in different 
countries.  It suggests that this will involve taking down existing barriers and develop ways of modernizing 
national regulatory systems.  However in some exceptional circumstances, Member States may take some 
action in relation to a service, from a provider established in another member state, relating to exercising a 
health profession.    
                                                     
8 Proposal for a Directive of the European Parliament and of the Council on services in the Internal Market 
http://www.labourline.org/DocumentYY.htm&numrec=031269668944140 
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3 Company overview 
 
All the companies outlined in this paper see European and other global opportunities for expansion in 
different aspects of the health care sector: insurance, clinical and diagnostic services, facilities management 
services and older people‟s care.  Partnerships with the public sector are seen as an essential step towards 
developing and delivering new services and facilities.  The involvement of these companies in the delivery of  
services in the healthcare sector, will have implications for health workers and for the accountability of 
public health systems.   
 
Companies involved in the healthcare sector in Europe can be divided into two main groups: 
3.1 Facilities management/ catering/ cleaning 
 
There are several global companies, such as Compass, ISS, Sodexho, Rentokil-Initial, and Aramark,  
which deliver a range of support services for several sectors, including the healthcare sector.  They deliver 
services such as catering, cleaning, buildings management, portering, reception. In the case of ISS and 
Rentokil – Initial, there is evidence of these larger companies buying small companies that had previously 
provided services to the healthcare and other sectors.  A process of consolidation has been taking place over 
the past decade. 9   
 
Aramark, Compass, ISS, Sodexho and Rentokil-Initial all have European Works Councils. These companies 
are active in the health and social care sectors to varying degrees.  ISS and Sodexho both have extensive 
activities in these sectors.  It is important to monitor whether any of these companies are expanding into 
health and social care.  For example, there are indications that Aramark is beginning to expand into the social 
care sector in the UK. 
 
3.2 Healthcare companies that provide healthcare directly 
 
A relatively small group of companies deliver healthcare in more than one country in Europe.  Capio is a 
Swedish healthcare company that is expanding in Northern Europe and France.  It focuses mainly on 
different ways of delivering acute care.  The company also runs residential homes for older people but this is 
not an area of expansion.  BUPA is involved as both a health insurer and healthcare provider in the UK and 
Spain, with health insurance activities in Ireland.  It has expanded in the past decade into residential care for 
older people and this has been a major source of growth as well as nursery care.  Day nurseries are the fastest 
growing small business sector in the UK with for-profit providers starting to expand their share of the 
market.10 
 
Gambro and Fresenius are both renal care companies that started by manufacturing products and equipment 
for kidney dialysis but have expanded in the last decade into managing dialysis clinics. The global renal care 
industry is highly competitive.  Both Gambro and Fresenius are exploring possibilities for home based renal 
care.  Fresenius is also moving into hospital management and cancer treatments. 
  
There are several issues facing companies providing healthcare directly.   
1. Companies view their relationships with government/ public healthcare sector as crucial to future 
company growth.  Some companies are building up their experience of working with the public 
sectors.   
                                                     
9 Hall D. Lethbridge J., Lobina E.,, Thomas S., and Davies S. (2002) The UK experience – privatised sectors and 
globalised companies A paper presented at the Cesifo/University of Warwick conference Munich, January 2003. 
10
 UNISON (2003) Nursery companies, UNISON Bargaining Support June 2003 
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2. Many companies involved in delivery of residential care for older people or people with disabilities 
are finding it difficult to make profits from this type of service.  This is leading to some companies 
withdrawing from the sector or deciding not to expand.  In some Scandinavian countries, residential 
homes have handed back to municipal control.  
 
3. There are several examples in Europe of governments contracting private companies to manage a 
public sector hospital.  In some countries this also involves the private company in building the 
hospital e.g. Private Finance Initiative in the UK.  Examples of hospitals where private healthcare 
companies have been contracted to run hospitals in the public sector are:  
 St.Goran‟s Hospital, Stockholm, Sweden – Capio  
 Ribera Hospital, Valencia, Spain - ADESLAS 
 Omegna Hospital, Piedmont, Italy – Generale de Sante 
 Hospital Amadora, Sintra, Portugal - Jose de Mello Saude  
 
4. The introduction of a system of Diagnostic Related Groups (DRGs), a system of costing and pricing 
episodes of patient care by governments, is seen by private healthcare companies as a way of gaining 
parity with public sector providers. 
 
5. Expansion into Central and Eastern Europe by healthcare companies has been slow.  Companies 
have found that the market for private healthcare is relatively small with the slow growth of middle 
income groups.  Companies involved in facilities management have expanded more rapidly into 
Central and Eastern European markets. 
 
6. The national regulatory environment is an important factor influencing the decisionmaking of 
companies.  An unstable or uncertain regulatory environment may leave companies undecided as to 
whether to invest, e.g. Eastern and Central Europe, Netherlands. 
 
Companies will be considered in the following groups. 
 
Companies eligible for EWCs 
 
Aramark 
BUPA 
Capio 
Compass 
Fresenius 
Gambro 
ISS 
Initial-Rentokil 
Sodexho 
 
Eligible after accession Euromedic, Medicover 
Non eligible Adeslas, Generale de Sante, Jose de Mello 
Saude, Marseille Klinikum, Paracelsus 
Kliniken, Rhon Kliniken 
 
PSIRU  University of Greenwich  www.psiru.org 
2 March 2004  Page 8 of 47 
3.3 EWC eligible 
 
Company 
name 
(company’s 
major owner) 
Major presence in 
Europe (countries) 
                       Workers EWC 
  Worldwide Europe Other  
Aramark UK, Czech Republic, 
Belgium, Spain, 
Hungary, Ireland 
200,000 39,800 
(non-US) 
- Yes 
BUPA UK, Ireland, Spain 9,120 9,120 - No 
Capio Sweden, Finland, 
Norway, Denmark, 
UK, France, 
Switzerland 
10,808 10,808 - No 
Compass 
 
France, Germany, UK, 
Switzerland, Spain, 
Netherlands, Sweden 
375,000 
 
 
  Yes 
Fresenius Austria, France, 
Germany, Sweden, UK, 
Italy, Spain, Belgium,   
63,638 26,091 
40% 
28,637 North America  
6,363 Latin America 
2,545 Asia- Pacific 
Yes 
Gambro Belgium, France, 
Germany, Hungary, 
Italy, Luxembourg, 
Netherlands, Poland, 
Portugal, UK 
20,900 7,106 
(34%) 
11,495 United States 
(55%) 2,299 Rest of 
world (11%) 
  
Yes 
ISS 
 
 
Denmark, UK, Sweden,  
Austria, Belgium, 
Croatia, Czech 
Republic, Denmark, 
Finland, France, 
Germany, Greece, 
Hungary, Iceland, 
Ireland, Italy, 
Luxembourg, 
Netherlands, Norway, 
Poland, Portugal, 
Romania, Slovakia, 
Slovenia, Spain, 
Sweden, UK  
248,500 203,528 
(81.9%) 
44,972 rest of world 
(18%) 
Yes 
Rentokil- 
Initial 
 
 
 
Austria, Belgium, 
Czech Republic, 
Denmark, Finland, 
France, Germany, 
Greece, Italy, The 
Netherlands, Norway, 
Portugal, Ireland, 
Spain, Sweden, 
Switzerland, UK   
92,447   Yes.  
Covers 
countries 
of EU, 
Norway 
and Switz-
erland 
Sodexho Austria, France, UK, 
Belgium, Finland, 
France, Germany, 
Hungary, Italy, 
Luxembourg, 
Netherlands, Spain, 
Sweden, and the UK.    
308,315 132,575 
(43%) 
117,119 United States 
(38%)  
58,579 Rest of world 
(19%)  
Yes 
PSIRU  University of Greenwich  www.psiru.org 
2 March 2004  Page 9 of 47 
 
3.4 EWC eligible after accession in 2004 
 
Company 
Name 
(company’s 
major owner) 
Major 
presence in 
Europe 
WORKERS EWC 
  Worldwide Europe Other  
Euromedic 
International 
Hungary, 
Romania, 
Bosnia 
Herzogovina, 
Croatia 
 
- 1,000 - No 
Medicover Estonia, Czech 
Republic, 
Hungary, 
Poland, 
Romania,  
- 1,200 - No 
 
3.5 Non-EWC eligible  
 
Company 
Name 
Major presence 
in Europe 
WORKERS 
  Worldwide Europe Other 
Adeslas Spain, France? Latin 
America 
Spain, 
France? 
Argentina 
Generale de Sante France, Italy, 
Switzerland 
Americas France, 
Italy  
Venezuela, 
Chile 
Jose de Mello 
Saude 
Portugal - Portugal Brazil 
Marseille Klinikum Germany - Germany - 
Paracelsus Kliniken Germany, 
Switzerland 
- Germany 
Switzerland 
- 
Rhoen Klinikum Germany - Germany - 
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3.6 Significant acquisitions and sales of subsidiaries 
 
Company Buying Selling Comment 
Capio 2002 Clininvest 
clinics, France 
2002 Clinique des 
Cedres, France 
2002 Scandinavian 
Heart Centre 
2003 Nova Medical 
Polska to Medicover 
2003 Clinique Marzet 
2004 Capio Previa   
Capio bought Clininvest clinics as part of 
its strategy to become a pan-European 
operator.  Clinique Marzet was sold to a 
local company which Capio felt was more 
suited to running the clinic.  Capio sold 
Nova Medical Polska because of the slow 
middle class growth in Poland.  
Capio Previa (occupational health) was 
sold to Segulah II, a Swedish private equity 
fund.  
Fresenius 
 
2002 Everest 
Healthcare Services 
Corporation USA 
 
2002 Seehospital 
Sahlenburg GMbH, 
Sahlenburg 
2002 Klinikum Rhein-
Seig GMbH  
2002 Klinikum-Rhein-
Seig Dienstleistungs 
GMbH, Seilburg   
 
2001, ProServe 
acquired 
Wittgensteiner 
Kliniken AG Bad 
Berleburg – 
  
 
 
 
 
 
 
 
 
 
 
 
 
Wittgensteiner Kliniken is one of largest 
private hospital operators in Germany with 
a subsidiary in Czech Republic 
Gambro  2002 Scandinavian 
Heart Centre 
Scandinavian Heart Centre sold to Capio 
Generale de Sante 2002 Centro Cardinal 
Ferrari, Italy 
2002 Centro 
Diagnostico San 
Niccolo, Italy  
2002 Clinique de Bois 
d‟Amour  
Regina  
2002 Teleservice 
Sante 
2002 Sante Boutique 
Clinique de Bruay 
Generale de Sante has a strategy to expand 
into Italy. 
ISS Ranas 
Rehabiliterubgcebter 
AB and Knivsta 
Rehabilitering AB, 
Sweden (100% )  
Jan-June 2002 
Kindergartens, 
Denmark  
November 2002 ISS 
supported a 
management buyout 
of Elderly Care (ISS 
CarePartner AB) and 
retains 49% of shares  
 
 
 
ISS has experience difficulties in making 
profits from residential care. 
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3.7 Global reach of companies 
 
Parent 
company 
Sales Healthcare division Sales % 
Aramark $9.4 billion n/a   
Compass £11,286 m Healthcare £1,467m 13% 
Fresenius €7,507 m Fresenius Medical Care €5,378 m 71% 
Gambro SEK 27,574 Healthcare SEK 16,872m 61% 
Rentokil 
Initial 
£2,339.5m n/a   
 
 
ISS DKK 37,984m  ISS Healthcare DKK 1,288 m  3.4% 
Sodexho €11,687 m Healthcare €2,220 m 19% 
 
3.8 Company involvement in PPPs 
 
Company Country Projects  
ISS UK  Mairmyres Stonehouse Hospital 
 Bromley Hospitals 
 Greenwich Healthcare 
 Rotherham General hospital  
 Walsgrave and St,.Cross 
 South Durham 
Healthcare(Bishop Auckland) 
 Worcester Royal Infirmary NHS 
Trust 
 Calderdale Healthcare NHS Trust 
 Redbridge Hospitals 
 West Berkshire NHS Trust 
 Barnsley District General 
Hospital 
 
Build and operate 
Sodexho UK  Kings‟s College Hospital, 
London  
 Queen Mary‟s Hospital. 
Roehampton 
 South Manchester University 
Hospital Trust (Wythenshawe 
Hospital), Manchester 
 Romford Hospital 
 Barts and the London NHS Trust 
 Manchester Royal Infirmary 
 Hereford Hospital 
 Northampton Mental Health 
 Queen Alexandra Hospital, 
Portsmouth 
 
 
Fresenius UK  Renal dialysis centre, Wales 
£1.8m/ 3.9m project at Conwy & 
Denbighshire NHS Trust's Ysbyty 
Glan Clwyd in Bodelwyddan.  
Fresenius Medical Renal Services 
will operate the centre once it has 
been built by Cochin Contractors Ltd 
Build  and operate 
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Capio Sweden  St. Goran‟s Hospital, Stockholm Private management of 
hospital for Stockholm 
County Council. Capio 
bought the hospital from 
Stockholm County Council  
in 2000 
Adeslas Spain  Ribera Public Hospital, Valencia Build and management of 
public hospital  
Jose de 
Mello 
Saude  
Portugal  Amadora Sintra Hospital, Lisbon  Build and management of 
public hospital 
Generale de 
Sante 
Italy  Omegna Hospital, North 
Piedmont, Italy 
Management of public 
hospital 
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4 Companies with EWCS or EWC eligible 
 
4.1 Company name  ARAMARK 
 
Owner ARAMARK 
1101 Market Street 
Philadelphia 
Pa 19107   USA 
www.aramark.com 
 
 
EWC: YES 
 
Total employees: 200,000 
 
Regional breakdown 
 
Activities Sales Employees 
United States 69% 145,000 
International food and support services 15% 39,800 
Uniform services 16% 15,000 
 
4.1.1 Major European subsidiaries 
 
Company Ownership Country Website 
Aramark 
Catering  
100% UK www.aramark.com 
Aramark 
Cleaning  
100% Belgium www.aramark.com 
Aramark Gmbh 100% Germany www.aramark.com 
Aramark 
Ireland 
Holdings Ltd 
100% Ireland www.aramark.com 
Aramark SA 100% Belgium www.aramark.com 
Dynamed UK 
Ltd 
100% UK www.aramark.com 
 
4.1.2 Company activities and strategy 
Aramark is a global company providing food, support and uniform services.  In 2001, the company 
purchased ServiceMaster Management Services. Although 69% of its sales are currently in the United States, 
the company has recently entered Ireland.  Aramark sold its childcare division (Aramark Educational 
Resources) to focus on food, facilities management and uniform businesses.  Aramark Educational 
Resources was sold in 2003 to California based Knowledge Learning Corporation Inc.11       
 
The company has recently gained a contract to supply BetterCare Ltd, a residential care company with 28 
private residential care homes in the UK.  It has also been awarded a contract with Jewish Care, one of the 
largest health and social care charities in the UK, to do catering, cleaning, housekeeping, laundry, ground 
and building maintenance, refuse collection and reception services.12      
 
                                                     
11 Associated Press State and Local Wire, 12 May 2003 
12 Aramark  Annual Report 
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4.2 Company name BUPA 
 
Owner:  
BUPA  
BUPA House 
Bloomsbury Way 
London WC1A 2BA 
www.bupa.com 
  
EWC: NO – ELIGIBLE 
 
Total employees:  9,120 (Europe) 
 
Regional breakdown (Europe) 
 
Country Number of  employees 
UK 6,950 
Ireland 170 
Spain 2,000 
Total 9.120 
 
4.2.1 Major European subsidiaries 
 
Company Ownership Country contact Website Employees 
Sanitas – Spain 100% Spain c/via Augusta 13-
15, 28042 Madrid 
Tel: + 902 10 24 00 
www.sanitas.es 
 
2,000 
BUPA Ireland 100% Ireland 12 Fitzwilliam 
Street, Dublin 2 
Tel: (01)662 7662 
Fax: (01)662 7672 
www.bupa.ir 
 
170 
BUPA 
Hospitals Ltd 
100% UK Bloomsbury Way, 
London WC1 
www.bupa.com 6,950 
BUPA UK 
Insurance 
100% UK  www.bupa.com 
BUPA Care 
Services Ltd 
100% UK  www.bupa.com 
BUPA 
Childcare 
Services Ltd 
100% UK  www.bupa.com 
Strand Nurses 
Bureau Ltd 
100% UK  www.bupa.com 
 
 
4.2.2 Company outline and strategy 
BUPA is one of the two largest providers of private health insurance in the UK with 40.1% of the market.  
PPP (now owned by AXA UK plc) has 29.1% of the market.  BUPA is also the largest provider of private 
healthcare in the UK.  The progress of BUPA during the last decade, the UK‟s largest private health care 
provider and health insurer, reflects the slow expansion of the private sector into acute health care in the UK.   
BUPA also operates in Spain, Ireland, Middle East, Thailand, Hong Kong, Singapore and Malaysia.   
 
In the last 10 years BUPA has expanded through a series of acquisitions in the UK and worldwide.  Its most 
striking area of expansion has been into care services.  BUPA Care Services consist of the three subsidiaries: 
BUPA Nursing Homes ltd, BUPA Care Services ltd and Care First Group plc.   BUPA runs 223 care homes, 
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54 sheltered retired homes and in 1999 cared for 26,000 people in residential care or through home care 
services.  BUPA has also expanded into nursing and other care services. 
 
In 1999, BUPA tried to buy the Community Hospitals Group in the UK, but was stopped by a Competition 
Commission ruling which argued that BUPA would dominate the market too strongly if the takeover went 
ahead.  This was one of several unsuccessful attempts by BUPA to expand into acute care the UK.  BUPA 
has managed to expand into residential and nursery care in the UK and, internationally, into primary and 
secondary care in Asia.   
 
BUPA was the first company to be invited to run a complete surgical centre on behalf of the NHS in 2002.  
This involved the NHS contracting with BUPA to run the Redwood Hospital, Surrey as a surgical centre for 
treating 5000 routine operations.  However, in October 2003, BUPA was not short listed to run one of the 
new Treatment Centres for the NHS, which involve direct contracting out of clinical services to private 
sector providers.   
 
BUPA Ireland was established in June 1996 and has offices in Fermoy and Dublin. It currently employs over 
170 staff and provides over 320,000 members with private health insurance throughout the country.  BUPA 
Ireland continues to offer cover for treatments not previously covered by health insurance in Ireland such as 
speech and language therapy and health screening. 
 
Sanitas is a Spanish health insurer and healthcare provider and was incorporated into BUPA in 1989.  It has 
1.3 million members with access to 20,000 doctors, 520 hospitals and medical centres.  Sanitas has recently 
made an agreement with United Healthcare, one of the largest insurers in the United States, which gives 
members of Sanitas Mundi (World Sanitas) access to four hospitals in the United States (MD Anderson 
Cancer Center-Houston, Massachusetts General Hospital (Boston), Mount Sinai Hospital – New York and 
John Hopkins Hospital –Baltimore).  
 
BUPA‟s most recent international acquisition was buying 50% of AXA Australia, the third largest insurer in 
Australia with 11% of the market.  
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4.3  Company name CAPIO 
 
Owner Capio AB 
Gullbergs Strandgata 9  
P.O. Box 1064  
SE-405 22 Göteborg, Sweden  
Tel: +46 31 732 40 00  
Fax: +46 31 732 40 99  
www.capio.com 
 
 
EWC: ELIGIBLE  (negotiations have started)  
 
Total employees: 10,808 (end 2003) 
 
Company divisional breakdown 
 
Company name Number of employees 
Capio Healthcare Nordic 3,401 
Capio Healthcare UK 2,702 
Capio Diagnostics 993 
Capio Elderly care 1,688 
Capio Sante (France) 317 
 
4.3.1 Major European subsidiaries 
 
Company Ownership Country Website 
Access 
Raduikigu AB 
100% Sweden www.capio.se 
 
Capio 
Diagnostikk AS 
100% Norway www.capio.se 
 
Capio Norge AS 100% Norway www.capio.se 
 
Capio Diagnostik 
A/S 
100% Denmark www.capio.se 
 
Capio  Sjukvard 
Norden AB 
100% Sweden www.capio.se 
 
Actica Omsorg 
AB 
100% Sweden www.capio.se 
 
Lundby Sjukhus 
AB 
100% Sweden www.capio.se 
 
LAkargruppen I 
Orebro AB 
91% Sweden www.capio.se 
 
Svenska 
Cityklinikerna 
AB 
100% Sweden www.capio.se 
 
Capio Diagnostik 
AB 
100% Sweden www.capio.se 
 
Smartkliniken 
Kronan AB 
100% Sweden www.capio.se 
 
Volvat 
Medisinske 
Senter AS 
100% Norway www.capio.se 
 
Nordiska 91% Sweden www.capio.se 
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Klinikerna AN  
St.Gorans 
Sjukhus AB 
100% Sweden www.capio.se 
 
Overseas 
Healthcare AN 
100% Sweden  
Anorexicenter I 
Varberg AB 
100% Sweden www.capio.se 
 
Societe 
Anonyme De La 
Metanie  
100% Switzerland www.capio.se 
 
Medocular AB 100% Sweden www.capio.se 
 
Mediscan OY 100% Finland  
Scandinavian 
Heart Center AB 
100% Sweden www.capio.se 
 
PGL 
Professional 
Genetis 
Laboratory AB 
100% Sweden www.capio.se 
 
Clininvest 100% France www.capio.fr 
 
Clinque des 
Cedres 
100% France  www.capio.fr 
 
UK Healthcare 
Limited 
Partnership Inc 
100% UK www.capio.co.uk 
 
 
4.3.2 Company activities and strategy 
Capio is a Swedish healthcare company which is aiming to become a trans-European healthcare company.  
Since 2001, it has acquired several healthcare companies in the UK, Finland and France.   
 
Capio‟s first acquisition in Finland was the Finnish radiology company, Mediscan Oy on February 1, 2002. 
Mediscan Oy works with magnetic resonance tomography (MR) and computer tomography (CT). It has 
annual revenues of FIM 10 M (approximately SEK 16 M), is based in Helsinki and has a smaller unit in 
Lahti. The company's personnel consist chiefly of radiologists and other medical professionals.  
 
In July 2001, Capio bought the UK Community Hospitals Group.  The following year, Capio sold its UK real 
estate portfolio, which was hospital buildings of the former Community Hospitals Group that Capio acquired 
in August 2001, to Nikko Principal Investments Limited.  The transaction was structured as a disposal of a 
majority stake in UK Healthcare Properties Limited Partnership, a new Limited Partnership specifically 
formed to hold Capio‟s UK real estate portfolio. Capio was to retain a 20 per cent stake in the Partnership. 
The investment cost was £8 million.  The Limited Partnership would hold 20 of Capios´ hospital properties 
in the UK. The leaseback period is 30 years with a break option for Capio at year 21. The agreement includes 
an option for Capio to extend the lease or purchase the properties at the end of the lease term. 
  
Per Båtelson, CEO of Capio commented 
"Following the successful acquisition of Community Hospitals Group last year, this transaction represents 
an important principle of Capio's overall strategy of not unnecessarily tying up capital or human resources 
in properties and their management." 
 
A year later, in June 2003, Capio acquired the outstanding 80 per cent in UK Healthcare Limited Partnership 
Inc from Nikko Principal Investments. The transaction means that Capio has 100-per-cent control of its UK 
hospital properties.   
 
In August 2002, Capio bought the Scandinavian Heart Centre in Gothenburg from Gambro, a renal care 
company. Scandinavian Heart Centre focuses on cardiovascular surgery and performs about 550 operations 
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each year. The company has a 6% share of the Swedish market.  The Scandinavian Heart Centre was 
established in 1985 and has been wholly owned by Gambro AB since 1994. Activities focus primarily on by- 
pass operations, cardiac valve surgery and operations to correct congenital heart disorders. The majority of 
the staff (70) are nurses with specialist training. 13  
 
In September 2002, Capio acquired France's second largest private health care provider, the Clininvest 
Group. Clininvest runs 16 hospitals in several regions and had a annual turnover of €120 million.   
 
In December 2002, Capio-owned Actica Omsorg has sold its 28.3 interest in Bokbacken Fastigheter AB to 
Kungsleden which thereby becomes the sole owner of Bokbacken Fastigheter AB. An agreement has also 
been reached whereby Actica will be able to lease space in future Kungsleden elder-care buildings. An 
agreement to work together to take advantage of future opportunities in elder care has also been prepared and 
the main aim is to jointly offer municipalities integrated solutions for retirement homes, covering both the 
property ownership and the operations. 
 
In June 2003, Capio sold the Polish laboratory medicine operation Nova Medical Polska to Medicover, a 
company also listed on the Stockholm Stock Exchange.  This was presented as a strategic decision to 
concentrate its diagnostics operations in the markets where the Group already has or is currently establishing 
healthcare operations.   
 
In October 2003, Capio bought Clinique des Cèdres in Toulouse, the largest private hospital in France. The 
hospital provides orthopaedic and neurology care services. During 2002, the hospital had revenues of slightly 
more than €50 million with 600 beds. The acquisition means that Capio “strengthens its position as a 
provider of internationally recognized high-quality care at competitive prices”. It also makes Capio the 
dominant player in the Toulouse region. 14  
 
In December 2003, Capio sold  its loss-making French unit Polyclinique Marzet to SAS Harpin, a local 
healthcare provider.  Polyclinique Marzet has annual revenues of approximately €15 M. Operations include 
surgery, oncology and medical treatment, but it also has an outpatient care department and radiology 
facilities. The clinic has 240 full-time employees. 15  Capio has experienced problems with this clinic in 
April 2003, when the clinic was closed by the French government because of complaints against the doctors.  
As doctors are not employed directly by the clinic, Capio did not have access to clinical notes relating to the 
cases.  The company had to wait until the government regulator decided the clinic could reopen several 
weeks later. 
 
In February 2004, Capio was named a preferred bidder to run several „spine clinics‟, part of the new 
Treatment Centres in the UK.  In October 2003, Capio was not on the shortlist of companies that the 
Department of Health announced it would contract to build and run the Treatment Centres, including 
providing clinical care.  Capio has managed to persuade the Department of Health and local Primary Care 
Trusts since then, that it could provide the „Spine clinics‟ at a cheaper price.  The Department of Health had 
also changed the specification from a day care centre to a centre providing care for several days.  The 
previously shortlisted company (Mercury Health) was unable to provide overnight care.  Capio will use some 
of its staff from the Nordic region to deliver the clinical care.16 
 
Also in February 2004, Capio sold its occupational health division, Capio Previa (1400 employees) to 
Segulah II, a Swedish private equity company. 17  
                                                     
13 Capio press release 20 August 2002 
14 Capio press release 10 October 2003 
15 Capio press release 30 December 2003 
16 Health Service Journal 27 February 2004 
17 Capio Press release 16 February 2004 
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4.4 Company Name COMPASS 
 
Owner 
Compass Group PLC 
Compass House 
Guildford Street  
Chertsey, Surrey KT1 9BQ 
Tel +44 1932 573 000 
Fax +44 1932 569 956  
www.compass-group.com 
 
EWC: YES 
 
Total employees: 375,000 
 
Regional breakdown 
 
Region Sales % 
UK £3,060m 
 
23% 
Continental Europe  £2,482m 22% 
North America £3,562m 32% 
Rest of world £1,918m 17% 
Total £11,286  
 
4.4.1 Major European subsidiaries 
 
Company Ownership Country 
Compass 
Contract 
Services (UK) 
Ltd 
100% UK 
Eurest France 
SA 
100% France 
Eurest 
Deutschland 
GmbH  
100% Germany 
 
4.4.2 Company activities and strategy 
The Compass group is a global food service company. Providing food in healthcare settings represents 13% 
of company turnover. Morrison and Medirest, two of the Compass brands, provide food services to 
healthcare and residential elderly care throughout the world.  Medirest was formed in 1999 following the 
merger of health, senior and social activities of Eurest and SHR.  Crothall provides facilities management 
services to the healthcare sectors, works with Morrison in the United States.  Compass does not run 
healthcare services directly. 
 
2003 was considered a challenging year with activities in France and Germany being affected by the 
economic slowdown.  The company is continuing to invest in infrastructure that it considers necessary to 
extract cost savings from its activities. 
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4.5 Company Name FRESENIUS 
 
Owner: Fresenius 
Head Office 
Fresenius AG 
Else-Kröner-Straße 1 
61352 Bad Homburg v.d.H. 
Germany 
Postal Address: 
Fresenius AG 
D-61346 Bad Homburg v.d.H. 
Tel: +49 6172 608 0 
www.fresenius.de 
 
EWC: YES 
 
Total employees: 63,638  
 
Regional breakdown 
 
Region Number of  employees % employees 
Europe 26,091 40% 
North America 28,637 45% 
Latin America and other 
regions 
6,363 10% 
Asia-Pacific 2,545 4% 
Total 63,638  
 
4.5.1 Major European subsidiaries 
 
Company Owner- 
ship 
Country Contact Website Employees 
Fresenius Kabi 
Deuschland 
Gmbh Frankfurt 
a M. 
100% Germany Fresenius Kabi 
Deutschland GmbH 
Else-Kröner-Strasse 1 
61352 Bad Homburg 
Tel: +49 (0)6172 686 0 
Fax +49 (0)6172 686 
2628 E-mail: 
communication@fresen
ius.kabi.com 
www.fresenius-kabi.de 
 
1,219 
Wittgensteiner 
Klinken Group 
Bad Berleburg 
93% Germany Im Herrengarten 1, 
57319 Bad Berleberg, 
Tel:02751/920-6 Fax: 
02751/920-760 E-mail 
info@wka.de 
 
www.wka.de 
 
6,704 
hospitalia Care 
Group 
Bad Lauterburg 
100% Germany info@hospitalia-care.de 
 
www.hospitalia-care.de 
 
522 
hospitalia 
Kliniken group 
100% Germany   329 
Fresnius Kabi 
France SAS 
Sevres, France 
100% France  www.fresenius-kabi.de 
 
506 
Fresenius Kabi, 100% Italy Fresenius Kabi Italia www.fresenius-kabi.de 260 
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Italy S.p.A, 
Verona 
S.P.A. 
Via Camagre, 41 
37063 Isola della Scala 
– Verona 
Tel:+39 045 6649 311 
Fax: 39 045 6649 404 
 
 
Fresenius Kabi 
Espana SA, 
Vilassar de 
Dalt, Spain 
100% Spain  www.fresenius-kabi.de 
 
168 
Fresenius Kabi 
Ltd, 
Warrington, 
England 
100% UK  www.fresenius.co.uk 
 
257 
Fresenius  Kabi 
Austria GmbH, 
Graz, Austria 
100% Austria  www.fresenius-kabi.de 
 
522 
VAMED 
Group, Vienna, 
Austria 
77% Austria Sterngasse 5, A-1230 
Vienna Tel:43/1/60 
127/0 Fax: 43/1/60 127/   
190 E-mail: 
office@vamed.co.at 
 
www.vamed.com 
 
1,658 
NPBI 
International 
BV, Emmen, 
Netherlands 
100% Netherlands NPBI International 
B.V. 
Runde ZZ 41 
7881 HM Emmer-
Compascuum Tel : +31 
591 355 700 Fax +31 
591 355 555 E-mail@ 
customer_services@np
bi.nl 
www.npbi.nl 
 
768 
Fresenius Kabi 
AB, Stockholm, 
Sweden 
100% Sweden Fresenius Kabi AB 
Rapsgatan 7, 
SE-751 74 Uppsala 
Tel:+46 18 64 4000 
Fax: +46 18 64 490 E-
mail: infor-
sweden@fresenius.kabi
.com 
www.fresenius-
kabi.com 
 
724 
 
4.5.2 Company activities and strategy 
Fresenius is a “global health care company with products and services for dialysis, the hospital and the 
medical care of patients at home”18.  As a vertically integrated renal care company, Fresenius produces 
products and equipment for renal dialysis and runs dialysis clinics.  Increasingly the company is becoming 
more involved in the production of infusion therapies for patients at home as well as for a wider range of 
conditions than renal care, e.g. cancer care.   
 
In addition, the Fresenius Chairman pointed out in 2001, that there was the potential for Fresenius ProServe, 
the international management division, to expand because “health systems, not only in Germany but all over 
the world, are in a state of change which is marked by increasing privatisation of hospitals and the demand 
                                                     
18 www.fresenius.de 
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for qualified, economically-efficient care of patients”. 19 Krick predicts that in Germany the current 7% of 
hospitals operated privately will increase and there will also be an increase in integrated hospital services 
where primary and secondary care are brought together. 
 
Fresenius is one of three global companies in the renal care market.  It is also one of several companies 
operating in the global medical devices industry that are involved in the expansion of homecare services.  In 
relation to renal care, Fresenius is keen to promote the use of peritoneal infusion as a way of treating patients 
with end stage renal disease. Peritoneal infusion involves introducing a solution into the abdominal cavity to 
absorb toxins and excess water and is a process that can be done at home.  It is cheaper than renal dialysis.   
 
In 2002, the company switched from re-use dialysers to single use dialysers in its American clinics.  They 
are already in use in Europe and Asia.  There is a lower risk of infection from using single use dialysers.  In 
the US, this change involved increasing capacity in its US production facilities and changing staff at its 
clinics.    The move in the US was also because of anticipated changes in reimbursement of dialysis care 
from payment per dialysis treatment to new types of fee-per-case reimbursement per dialysis patient.  
Fresenius thinks that the new system of reimbursement offers opportunities to offer products and services as 
a package.  The move from re-usable dialysers to single use dialysers is affecting the renal care market.  20 
 
As an indication of Fresenius‟ widening approach to its business, Fresenius is also moving into the 
production and treatment of cancers using immunotherapies.  Clinical trials are in progress.  
                                                     
19
 Speech by Gerd Krick, Fresenius President at AGM 2001 
20
 Merrill Lynch (2001) Kidney Machinations The Dialysis Industry Could get Bloody   
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4.6 Company Name GAMBRO 
 
Owner  
Gambro AB 
Head Office 
mailing address: P.O Box 7373 
SE-103 91   
STOCKHOLM 
visiting address: Jakobsgatan 6 
103 91  STOCKHOLM 
Tel: + 46 - 8 613 65 00 
Fax: + 46 - 8 611 28 30 
www.gambro.com 
 
EWC: YES 
 
Total employees: 20,900 
 
Regional breakdown 
 
Region Number of employees % employees 
Europe 7,106 34% 
United States 11,495 55% 
Rest of world 2,299 11% 
 
4.6.1 Major European subsidiaries 
 
Company Ownership Country contact Website 
Gambro 
Dialysatoren 
GmbH &Co 
KG 
100% Germany Gambro Dialysatoren 
GmbH & Co KG  
mailing address: 
Postfach 1323 
DE-72373 
HECHINGEN 
visiting address: 
Ermelesstrasse 76 
(Research Dept.) 
72379 HECHINGEN 
Tel:  + 49 - 7471 17 0 
Fax: + 49 - 7471 17 1152 
www.gambro.com 
 
Hospal SpA 100% Italy Hospal S.p.A. (Sales) 
Via Ferrarese 219/9 
IT-40128 BOLOGNA 
Tel:  + 39 - 0 516 382 
411 Fax: + 39 - 0 516 
382 660 
 
Gambro 
Lundia AB 
100% Sweden Gambro Lundia AB  
Box 10101 
SE-220 10 LUND 
visiting address: 
Magistratsvägen 16 
Tel:  + 46 - 46 16 90 00 
Fax: + 46 - 46 16 96 96 
www.gambro.com 
 
 
 
PSIRU  University of Greenwich  www.psiru.org 
2 March 2004  Page 24 of 47 
4.6.2 Company activities and strategy 
Gambro, together with Fresenius, is one of three global renal healthcare companies.  In the last decade it has 
expanded from manufacturing products for renal dialysis to running dialysis clinics.  Gambro makes dialysis 
products, operates dialysis clinics and supplies blood bank technology worldwide.  Its vision is to be a 
globally preferred partner among patients and healthcare providers by providing blood and cell based 
solutions and services. Gambro‟s overall strategy is to: 
 Focus on three core businesses, renal products, renal services and blood component technologies  
 Provide leading capabilities for dialysis care, blood and cell collection and processing by drawing on 
Gambro‟s tradition of innovation, strong brands, global organisation and professional and dedicated 
employees 
 Enhance global scale and presence in selected markets 
 Manage risk and return in existing businesses as well as in selected new growth opportunities  
 
In 2002 Gambro entered the Turkish markets through the acquisition of the Bulten dialysis centre which 
included both product sales and clinic activities.  Like Fresenius, Gambro is also investing in single use 
dialysers and peritoneal dialysis. 
 
In June 2002, Gambro AB signed a 10 year loan of €150 milion with the European Investment Bank.  This 
will support current and new investments in Lund, Sweden and Germany as well as the construction of two 
new plants for synthetic dialysers.  Gambro also sold its open heart centre, the Scandinavian Heart Centre to 
Capio in 2002. 
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4.7 Company Name RENTOKIL INITIAL 
 
Owner   
Rentokil Initial plc 
Head Office 
Felcourt 
East Grinstead 
West Sussex 
RH19 2 JY 
Tel: +44 1342 833 022  
Fax: +44 1342 833029 
www.rentokil-initial.com 
 
EWC: YES 
 
Total employees: 92,447 
 
Regional sales 
 
Region Sales £m 
United Kingdom 1,153.4 
Continental Europe 771.7 
North America 315.1 
Asia Pacific and Africa 131.9 
Total 2,372  
 
4.7.1 Major European subsidiaries 
 
Company Ownership Country Website 
Initial Contract 
Services Ltd 
100% UK www.rentikil-
initial.com 
 
Initial Hospital 
Services Ltd 
100% UK www.rentikil-
initial.com 
 
Initial Catering 
Services Ltd 
75%  www.rentikil-
initial.com 
 
Rentokil Initial 
Services Ltd 
100% UK www.rentikil-
initial.com 
 
Rentokil Initial 
UK Ltd 
100% UK www.rentikil-
initial.com 
 
Rentokil Initial 
NV 
100% Belgium www.rentikil-
initial.com 
 
Rentokil Initial 
A/S 
100% Denmark www.rentikil-
initial.com 
 
Rentokil Initial 
Ltd 
100% Ireland www.rentikil-
initial.com 
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Oy Rentokil 
Initial AB 
100% Finland www.rentikil-
initial.com 
 
Rentokil Initial 
SA 
100% France www.rentikil-
initial.com 
 
Rentokil Initial 
GmbH 
100% Germany www.rentikil-
initial.com 
 
Rentokil Initial 
BV 
100% Netherlands www.rentikil-
initial.com 
 
Rentokil Initial 
Espana SA 
100% Spain www.rentikil-
initial.com 
 
Rentokil Initial 
AB 
100% Sweden www.rentikil-
initial.com 
 
 
 
4.7.2 Company activities and strategy 
Rentokil Initial is one of the largest business services companies in the world, providing a range of support 
services.  It operates in four major sectors: hygiene, security, facilities management and parcels delivery.  It 
aims to continue to develop its business services in the major developed economies of the world, with a 
range of high growth and quality driven sectors, which generate cash and are in less cyclical markets using 
the strength of the Initial and Rentokil brands.  The company does not deliver healthcare services but  
delivers cleaning and support services to hospitals. 
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4.8 Company Name ISS 
 
Owner International Service Systems ISS 
ISS A/S 
Bredgade 30 
DK-1260 Copenhagen K 
Denmark 
Tel:  +45 38 17 00 00 
Fax: +45 38 17 00 11 
www.issworld.com 
 
EWC: YES 
 
Total employees 248,500 
 
Country breakdown 
 
Country Number of employees 
United Kingdom 37,272 
France 36,412 
The Netherlands 26,270 
Central Europe 18,199 
Germany  14,185 
Denmark (incl Iceland and Greenland) 14,022 
Sweden 12,311 
Belgium and Luxembourg 11,511 
Norway 8,032 
Switzerland 7,145 
Spain 6,660 
Finland 6,538 
Israel 5,302 
Portugal 2,448 
Ireland 1,906 
Italy 617 
Asia (China, Singapore, Japan, Thailand, 
Indonesia, Brunei, Sri Lanka, Australia)  
23,980 
 
Latin America (Brazil, Argentina) 13,061 
Total 248,500 
 
4.8.1 Major European subsidiaries 
 
Company Ownership Country Contact Website Employee
s 
ISS 
Denmark 
A/S 
100% Denmark ISS Denmark A/S, 
Montmestervej 31,DK-2400 
Kobenhaven NV Tel:+45 38 
17 1717 Arne Pedersen 
www.dk.issworld.com 
 
14,022 
ISS France 
SAS 
100% France ISS ABilis France, 66-67. rue 
Ordener F-75018 Paris, 
France  
Tel:+33 1 44 9248 48 
Hubert Boisson 
www.fr.issworld.com 
 
36,412 
ISS 
Deutschland 
GmbH 
100% Germany ISS Holding GmbH, 
Keriastrasse 24 D-47269 
Duisburg Tel:+49 203 9982 0 
www.de.issworld.com 
 
14,185 
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Rob Alsema 
ISS 
Servisystem 
SA 
100% Greece ISS Servisystem SA, 
Demirdessious Str. 213, GR-
142  33 Nea Ionia Tel:+309 
10 27056 00-9 
Michelis Roussos 
www.gr.issworld.com 
 
 
ISS Ireland 
Ltd 
100% Ireland ISS Ireland Ltd 11-13 Malpas 
Street, Dublin 8 Tel:+353 1 
453 7711 
www.ie.issworld.com 
 
1,906 
ISS Suomi 
Oy 
100% Finland ISS Suomi Oy, Laulukuja 6, 
FIN-00421 Helsinki Tel:+358 
205 155 
Matti Kyytsonen 
www.fi.issworld.com 6,538 
ISS 
Netherland 
BV 
100% Netherlan
ds 
ISS Netherlands, Atoomweg 
484-6, NL-3542 AB Utrecht 
Tel:+31 30 242 43 44 Gerard 
Brand 
www.nl.issworld.com 
 
26,270 
ISS Norge 
A/S 
100% Norway ISS Norway a.s.,Ulvenveien 
83, Postboks 132 Okern N-
0509 Oslo Tel:+ 47 2288 
5000 
Bjorn Nilsen 
www.no.issworld.com 
 
8,032 
ISS Sverige 100% Sweden ISS Sverige AB 
Arstaangsvegen 25, Box 
42071, S-126 13 Stockholm 
Tel:46 8 681 60 00  
Thomas Kolbe 
www.se.issworld.com 12,311 
ISS UK Ltd 100% UK ISS UK Ltd. Wells House, 65 
Boundary Road, Woking, 
Surrey GU21 5BS Tel:+44 
1483 754 900 
www.uk.issworld.com 
 
37,272 
ISS 
European 
Cleaning 
Systems SA 
100% Spain  www.es.issworld.com 
 
6,660 
 
4.8.2 Healthcare subsidiaries 
 
Name Ownership Country Contact website Employees 
CarePartner 
AB 
49% Sweden ISS Health Care  
Tel:  08-690 55 00 
VD Hans John 
Øiestad 
Tel: 08-681 60 00 
hans.john.oiestad@is
s-sverige.se 
www.iss-sverige.se 
 
3,900  
FysiologLab I 
Stockholm 
AB 
100% Sweden  www.iss-sverige.se 
 
56  
ISS 
Healthcare 
AB 
100% Sweden  www.iss-sverige.se 
 
 
ISS Rehab 100% Sweden ISS Rehab AB, 
Stenbäckens & 
Linnéagårdens 
Behandlingshem 
Box 154, 598 22 
Vimmerby              
www.iss-sverige.se 
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Tel: 0492-75 000 
Fax: 0492 750 30 
Besöksadress: 
Stenbäcksgatan 16 
E -post: 
info@stenbacken-
linneagarden.se 
M&M 
Medical 
Holdings AB 
100% Sweden  www.iss-sverige.se 
 
360 
ISS Hospital 
Service AG 
100%  Switzerland  www.iss-sverige.se 
 
 
 
 
4.8.3 Company activities and strategy 
International Service Systems ISS is a Danish company providing facilities services including cleaning, 
catering, and services for hospitals and older people‟s care homes.  It works in a range of sectors and 
operates through the following divisions: 
 Cleaning and maintenance - office cleaning for private and public sectors 
 Services for the health sector - targeted at hospitals and other institutions within the health sector  
 Services for the food industry   
Other business areas include: Canteen/catering services; energy/industrial high tech services; property 
services, care services and after-damage service.  
 
Facility services represent 87% of sales in 2002.  Some of these are delivered in the hospital sector.  
Healthcare services, e.g. psychiatric care, contribute 3.4% of sales. 
 
Create 2005 is a new 5 year vision launched in November 2000.  It develops service concepts from multi-
services to facility services which is leading to integrated facility services.  Separate business areas are being 
managed across country borders.  The development of the facilities services package is most developed in 
the UK.  Specialisation of cleaning concepts is most developed in Germany (www.issworld.com).  ISS has 
also lost several contracts with the public sector in Denmark due to poor standards of delivery. 21 
 
ISS has made a large number of acquisitions in the last few years. In the health sector, it has acquired a 
number of older people‟s facilities and medical facilities but in some cases it has also divested of recent 
acquisitions in the health care sector.  In 2002, the CarePartner division, which delivers medical facilities and 
older people‟s care in Denmark, Sweden, Norway and Finland was reviewed. In November 2002, ISS 
supported a management buyout for its Elderly Care services, whilst retaining 49% of the shares.  The ISS 
Healthcare division was set up to focus on the expansion of direct healthcare.  ISS is also active in 11 Private 
Finance Initiatives (PFI) in the UK as both a provider of facilities management services and as an investor. 
 
4.8.4 ISS involvement in 11 Private Finance Initiatives (PFI) in the UK 
 
Name of hospital Turnover Start of services Contract length 
Mairmyres Stonehouse 
Hospital 
£6.90m April 2001 30 years 
Bromley Hospitals 5.00m April 2003 10.5 
Greenwich Healthcare 5.70m June 2001 5 
Rotherham General 
hospital 
2.50m 2000 15 
South Durham 2.50 May 2002 30 (subject to 
                                                     
21 Global Newswire 31 October 2001, 7 December 2001 
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Healthcare(Bishop 
Auckland) 
service review and 
market testing after 
5 years 
Worcester Royal 
Infirmary NHS Trust 
7.50 April 2002 30 (subject to 
service review and 
market testing after 
5 years 
Calderdale Healthcare 
NHS Trust 
4.70 April 2001 30 
Redbridge Hospitals 0.40 March 2002 5 
West Berkshire NHS 
Trust 
1.70 2003 5 
Barnsley District 
General Hospital 
1.50 January 2002 15 
Walsgrave and 
St,.Cross 
13.00 December 2002  
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4.9 Company Name SODEXHO 
 
Owner  
Sodexho Group 
Parc d'Activites du Pas-du-Lac 
3 avenue Newton 
78180 Montigny-le-Bretonneux 
France 
Tel : +33 01 30 85 75 00 
Fax : +33 01 30 43 09 58 
www.sodexho.com 
 
EWC: YES 
 
Regional employees and sales 
 
Region Employees % Sales % 
North America 117,159 38% €5,376m 46% 
Continental Europe 80,161 26% €3,737 32% 
UK/ Ireland 52,411 17% €1,518m 13% 
Africa, Asia and 
Pacific rim 
30,831 10% €350 5% 
Latin America 27,747 9% €584 3% 
Total 308,315  €11,687  
 
4.9.1 Major European subsidiaries (highest revenues for 2002-3) 
 
Company Ownership Country contact Website 
Sodexho Ltd 100% 
Sodexho 
Holdings Ltd 
(68% 
Sodexho 
Alliance SA) 
United 
Kingdom 
(54,322) 
Sodexho Ltd 
Kenley House 
Kenley Lane 
KENLEY 
Surrey 
CR8 5ED 
Tel:020 8763 1212 
Fax:020 8763 1044 
http://www.so
dexho-uk.com/ 
 
Sodexho BV 100% 
Sodexho 
Holdings Ltd 
(68% 
Sodexho 
Alliance SA) 
Netherlands Capelle aan den 
IJssel 
Rivium Boulevard 2 
2909 LK CAPELLE 
AAN DEN IJSSEL 
Tel.: (010) 288 4288 
Fax: (010) 288 4222 
info@sodexho-
nl.com 
 
http://www.so
dexho-nl.com/ 
 
Altys 
Multiservice 
SA 
80% 
Sodexho 
Alliance 
France  www.altys.fr 
 
Sogeres SA 100% 
Sodexho 
Alliance 
France 42/44 Rue de 
Bellevue 
92105 Boulogne 
www.sogeres.f
r 
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Billancourt France 
Tel :  +33 1 46 99 
33 33 Fax :  +33 1 
46 05 55 59 
contact@sogeres.fr 
 
Sodexho 
Italia SPA 
100% 
Sodexho 
Alliance 
Italy sede@sodexho-
it.com 
 
http://www.so
dexho-it.com/ 
 
Sodexho 
Belgique SA 
100% 
Sodexho 
Alliance 
Belgium Services Catering et 
Gestion de Services 
11 rue des Trois 
Cantons 
L-8399 Windhof 
Grand Duché de 
Luxembourg 
Commercial : Marc 
Wolwertz 
Tél : +352 
26.106.281 
Fax : +352 26109 
209 
e-mail : 
marc.wolwertz@sod
exho.lu 
 
www.sodexho-
be.com 
 
Sodexho 
Catering and 
Services 
GmbH 
100% 
Sodexho 
Alliance 
Germany info@sodexho.de 
 
www.sodexho.
de.com 
 
 
 
4.9.2 Company activities and strategy 
The Sodexho Group works in the following sectors: business and industry, defence, correctional services, 
healthcare, education, older people as well as in remote sites.  It also manages vouchers and card schemes.   
 
In the healthcare sector, Sodexho provides a range of services (often described as multi-service) to hospitals 
and to older people‟s care homes.  These services may include, catering, cleaning, housekeeping, building 
maintenance and management of paramedical staff.  Services delivered within the health care sector provide 
19% of revenue (Annual report 2002-3).  
 
Sodexho sees opportunities in global multi-site, multi-service contracts.  It is developing partnerships with 
public and private sector organisations in order to deliver services.  In the UK it is involved in several PFI 
project both as an operator and as an investor. 
 
The company has six strategic objectives: 
 Accelerate organic growth 
 Improve human resources planning 
 Improve operational management 
 Improve cash flow 
 Reinforce control 
 Encourage transparency and communication 
 
Sodexho PFI projects in the UK 
 
 Kings‟s College Hospital, London  
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 Queen Mary‟s Hospital. Roehampton 
 South Manchester University Hospital Trust (Wythenshawe Hospital), Manchester 
 Romford Hospital 
 Barts and the London NHS Trust 
 Manchester Royal Infirmary 
 Hereford Hospital 
 Northampton Mental Health 
 Portsmouth Queen Alexandra Hospital 
PSIRU  University of Greenwich  www.psiru.org 
2 March 2004  Page 34 of 47 
 
5 Companies likely to be EWC eligible after EU accession 2004 
 
5.1 Company name EUROMEDIC INTERNATIONAL 
 
COMPANY EUROMEDIC INTERNATIONAL N.V.  
Central European Headquarters 
Gerbeaud House  
1, Dorottya St.  
1051 Budapest  
Hungary 
TEL.: +36 1 267 5314 
FAX: +36 1 267 5312 
E-mail: joseph.priel@euromedic-group.com 
www.euromedic-group.com 
 
EWC:  NO 
 
Total employees 1,000 
 
5.1.1 Major European subsidiaries 
 
Company ownership Country Contact Website 
Euromedic 
Diagnostics 
BV 
100% Hungary EUROMEDIC INTERNATIONAL 
N.V. - Central European 
Headquarters 
Gerbeaud House, 1. Dorottya St., 
1051 Budapest, Hungary 
TEL.: +36 1 267 5314 FAX: +36 1 
267 5312 E-mail: 
joseph.priel@euromedic-group.com 
 
www.euromedic-
group.com 
International 
Dialysis 
Centre BV 
100%    
Euromedic 
International 
NV 
 Netherlands Holding company registered in The 
Netherlands 
 
Euromedic 
Bosnia Herz 
100% Bosnia 
Herzogovina 
EUROMEDIC Bosnia & 
Herzegovina 
Address: Bana Milosavljevica 8, 
Street, 78000 Banja Luka 
Republic of Srpska 
Bosnia and Herzegovina 
Contact person: 
Mr. Marijan Bilic 
IDC General Director 
email: mbilic@inecco.net 
Mobile Phone:00-387-65-513-104 
or 00-387-65-633-778 
Telephone: 00-387-51-22-33-40 
www.euromedic-
group.com 
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Fax: 00-387-51-22-33-50 
 
Euromedic  
Hungary 
100% Hungary EUROMEDIC DIAGNOSTICS Kft 
Gerbeaud House, 1. Dorottya St., 
1051 Budapest, Hungary 
Contact person: Dr. Zoltan Katona 
Tel: +361 327 4345 
Fax: +361 318 8687 
Email: katona.zoltan@euromedic-
group.com 
 
www.euromedic-
group.com 
Euromedic 
Poland 
100% Poland EUROMEDIC International Polska 
Sp. z o.o. 
ul. Krucza 16/22, 00-526 Warszawa 
tel. (+48 22) 627 28 98, fax (+48 
22) 627 28 99 
e-mail: euromedic@euromedic.pl 
Contact person: Dr. Maciej 
Kowalski, President Euromedic 
Poland 
 
www.euromedic-
group.pl 
 
Euromedic 
Czech 
Republic 
100% Czech 
Republic 
EUROMEDIC Czech Republik, 
s.r.o., Malostranské nám. 5 
110 00 Prague 1 
tel. (+42) 257535948, fax.(+42) 
257535952 
e-mail: D.Karasek@seznam.cz 
Contact person: Mr. David Karasek, 
Managing Director 
 
www.euromedic-
group.com 
Euromedic 
Croatia 
100% Croatia EUROMEDIC International d.o.o. 
Croatia, Kneza Borne 2, (1st Floor, 
Business Gallery, Sheraton Zagreb 
Hotel), 100000 Zagreb, CROATIA 
Tel.: +385 (0)1 46-46-777; or 778 
Fax: +385 (0)1 46-46-780 
e-mail: euromedic@inet.hr or: 
bg.euromedic@mail.inet.hr 
web-site: www.euromedic-
group.com 
Contact person: 
Branko Gracanin, General Manager 
www.euromedic-
group.com 
Euromedic 
Romania 
100% Romania EUROMEDIC Romania SRL 
35, Ermil Pangratti St., 5th level, 
Suite 5, Sect. 1, Bucharest - 
Romania 
Tel/Fax; +40 1 230 23 13, + 40 1 
231 26 45, + 40 1 231 26 49 
E-mail:office@euromedic.ro 
Contact person: Mr. Zahal Levy, 
President Euromedic Romania 
 
www.euromedic-
group.com 
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5.1.2 Company activities and strategy 
Euromedic Diagnostics BV and International Dialysis Centre BV are both 100% owned Dutch subsidiaries 
of Euromedic International NV, a holding company of the group (www.euromedic-group.com).   
 
For more than a decade, Euromedic has been building and operating Imaging Diagnostic Centres and 
Dialysis Centres in Eastern and Central Europe.  They work in a Public-Private Partnership (PPP.  
Euromedic invests in the centres and the public healthcare system pays for the service. The company‟s 
medical centres are fully integrated into the public healthcare system, based on contracts signed with the 
National Insurance institutes and supported by the Ministry of Health.   
 
Euromedic currently operates diagnostic imaging centres in Hungary and Poland and haemodialysis centres 
in Poland and Bosnia.  In Hungary, it has 7 private diagnostic imaging centres seeing 20,000 patients per 
month.  100-150 staff, mainly doctors, are employed in Hungary.  In Poland, Euromedic has 3 diagnostic 
imaging centres and 3 haemodialysis centre seeing 2,500 patients per month.  In Bosnia, it has one 
haemodialysis centre which sees 230 patients per month (www.ifc.org). The company aims to continue to 
expand in Eastern and Central Europe.  
 
Euromedic has also received a $13 million loan from the International Finance Corporation to fund a $33 
million expansion programme in Central and Eastern Europe.  Other shareholders include GE Equity – 
private equity arm of GE Capital, Dresdner Kleinwort Benson private equity fund, Global Environment 
Fund, RPM Partners, a Dutch private investment company and private investors led by Euromedic‟s 
management.  One of the non-executive Directors of Euromedic (Janusz Heath) is the head of Central and 
Eastern European Private Equity Dresdner Kleinwert Benson.  The company is also BRE Bank (Poland) and 
by CIB and OTP Banks (Hungary).  The current website lists three major shareholders: GE Capital; Dresdner 
Kleinwort Wasserstein (part of the Allianz Group); Global Environmental Fund. 
 
Euromedic International N.V. is today the largest investor in healthcare in Central and Eastern Europe. In 
2003, the Company owns and operates 35 Diagnostic and Dialysis Centres in Poland, Hungary, Romania, 
Bosnia and Croatia. The company uses brand names for different lines of activities: International Medical 
Centres (IMC), International Dialysis Centres (IDC) and Euromedic Trading.  The Headquarters of 
Euromedic are located in Budapest, Hungary. Euromedic employs about 1000 people. 
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5.2 Company name MEDICOVER 
 
Owner   
Medicover Holding SA  
20 rue Phillippe II,  
L-234- Luxembourg 
Tel: +352 26203110  
Fax: +352 2620 3234 
 
Medicover c/o Beiro Medical SA,  
Waterloo Office Park  
Building O, Dreve Richelle 161  
B-1410 Waterloo, Belgium  
Tel: +32 3 357 55 77  
Fax: : +32 3 357 55 05  
E-mail: info@medicover.com 
 
EWC: NO 
 
Total employees: 1,260 
 
Regional breakdown 
Company name Number of employees (2001) 
Medicover Poland 678 
Medicover Romania 330 
Medicover Hungary 96 
Medicover Estonia 68 
Medicover Czech Republic 70 
Medicover Laboratories 18? 
Total 1,260 
 
5.2.1 Major European subsidiaries 
 
Company Ownership Country Contact Website Employees 
Medicover 
(Czech 
Republic) 
100 Czech 
Republic 
Medicover Czech 
Tylovo nam, Praha 2, 
Czech republic 
Tel:+420 24251319 
Fax: +420 2425 5730 
E-mail info@medicover.cz 
www.medicover.cz 70 
Medicover 
Aesti AS  
81% Estonia Medicover Estonia, 
Gonsiori 33, 10147, 
Tallinn, Estonia Te;+372 
605 1555 Fax: +372 605 
1515 
E-mail: info@medicover.ee 
 
www.medicover.es 
 
68 
Medicover 
Klinika Rt. 
100% Hungary Medicover Hungary, 1138 
Budapest Vaci ut 22-24, 
Hungary  
Tel:+36 1 465 3150 Fax: 
:+36 1 465 3160 E-mail 
www.medicover.hu 
 
96 
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info@medicover.hu 
  
Medicover 
Rombel 
SRL 
100% Romania Medicover Romania Union 
International, Business 
Center II, 26-28 Stirbei 
Voda St.7th floor, Sector 1, 
Bucharest, Romania. 
Tel:+4021 314 0702 Fax: 
+4021 314 0775 E-mail 
Romania@medicover.com 
 
www.medicover.ru 
 
 
330 
Medicover 
Sp.zo.o. 
100% Poland Medicover Poland, 10, 
Sapiezynska Street, PL-00-
215 Warsaw, Poland Tel: 
+48 22 455 44 00 Fax: +48 
22 531 41 11 
E-mail: info@medicover.pl 
www.medicover.pl 
 
678 
 
5.2.2 Company activities and strategy 
Medicover‟s aim is to become the leading private healthcare company in “Emerging Europe”. Medicover has 
281 facilities with 48 fully owned and controlled and 233 partnership clinics in 5 countries.   
 
Medicover was established in 1995 by Oresa Ventures, a Swedish venture capital company.  The company 
offers both medical insurance and a health care delivery system, to its clients. Medicover employs most of its 
physicians directly and provides health care through its own facilities. In 2002, it has 77,600 pre-paid 
members in Poland, 14,000 in Romania, 1,700 in Hungary and 24,000 in Estonia.  It provides health 
insurance for corporations and individuals, health care services through 20 Health Centres staffed by its own 
doctors and nurses, and on-site workplace facilities for large employers. 
 
Although originally a project supported by venture capital company Oresa Ventures,  Medicover has become 
so successful that Oresa Ventures ceased to invest in new initiatives. ORESA Ventures' other holdings are 
being divested. As a result of the new focus, ORESA Ventures' name changed to Medicover and it become 
an operating healthcare company (www.oresaventures.com).  It has received a loan of $7 million from the 
International Finance Corporation out of a capital investment budget of $22million (www.ifc.org). 
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6 Non-EWC eligible companies 
6.1 Company name  ADESLAS 
 
Compania de Seguros Adeslas SA 
Principe de Vergara, 110 
10 – 28002 Madrid  
Spain 
Tel: 91 566 50 00 
Fax: 91 563 43 20 
www.adeslas.es 
 
Owners  
Aguas de Barcelona 75% 
Mederic 25% 
 
EWC: NO 
 
Number of employees: 
 
6.1.1 Company activities and strategy 
Adeslas is a Spanish health care company operating both health insurance and health care services.   Its 
insurance division specialises in the production, management and distribution of health insurance policies. It 
has about 1.5 million members and about 25% of the Spanish health insurance market.   
 
The healthcare management division directly manages 11 clinics and hospitals with over 1000 beds.  Adeslas 
took over the management of the Ribera Public Hospital in Valencia in 1998.  This was an initial attempt by 
the regional government to privatise public hospitals.  There have been reductions in staff and in the quality 
of service since Adeslas started to manage the hospital. 
 
The Valencia Government was one of the first regional governments to use private management methods in 
the public health sector.  On 1 January 1999, Adeslas, a Spanish health insurance and health services 
company took over the management of Alzira Hospital, previously the publicly owned Hospital de la Ribera, 
Valencia.   Adeslas (51%) together with two banks - Bancaixa and the Caja de Ahorros del Mediterráneo 
(45%) - and two construction companies - Dragados  (construction and services) and Lubasa (2% each) – 
formed the Union Temporal de Empresas (UTE), which was given the concession to build and manage the 
public hospital for 10 years.  The group was paid a set amount per head of population each year, initially 
34,000 pesetas per head. 22    
 
Before the hospital opened, trade unions were challenging the lack of transparency about the arrangements 
for terms and conditions of employment at the new hospital.  The new system of pay and conditions that was 
finally introduced was one of the main innovations of private management.  Each specialty had its own 
salary scale and its own set of objectives.  The rest of the 700 workers would receive a fixed pay rate. 23 All 
staff would be contracted. 
 
In November 1999, trade unionists from the General Union of Workers (UGT) demonstrated against the 
dismissal of a doctor who headed the list of candidates in the union elections in the hospital.  A member of 
                                                     
22 El Pais 21 January 1999 
23 El Pais 12 December 1998. 
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the committee of the UGT Federation of Public Services called for “the end of anti-trade union practices in 
the Health Committee of the company UTE – Adeslas” which was in charge of managing Alzira Hospital. 24  
 
A year later in December 2000, the health worker section of the national trade union Confederación Sindical 
de Comisiones Obreras (Federación Estatal de Sanidad of CC OO) challenged the legality of the concession 
for the management of the Alzira hospital arguing that the arrangement had led to the privatisation of the 
hospital and was outside the terms of the law 13/1995 of the Contracts of Public Administration.  The union 
argued that the removal of the medical personnel from the public hospital had led to “an illegal transfer of 
labour” to Adeslas (the company managing the hospital) “as means of production and profit”.  The 
Constitutional Tribunal did not uphold the trade union challenge. It argued that, “the character of the public 
system would not be influenced by the form of management or private responsibility”.25 Although the 
challenge was unsuccessful, this was an example of trade union challenging the legality of one aspect of the 
liberalisation of the public health system. 
 
In November 2002 the Valencia government announced that it would compensate the group of companies 
who had taken over the concession with €43.9 million, the value of the remaining 6 years of the contract.  
From 1999 – 2002 the group of companies (UTE) operated the hospital at a loss. The Valencia government 
actually paid the group €69 million in 2002, which was €25 million more than it had originally announced it 
would pay as compensation.  The government explained that this was payment for “lost profit” (lucro 
cesante).26 In December 2003, the Sindicatura de Cuentas of the Valencia government reported that it 
considered the annulment of this contract to be outside the remit of public administration contract law. 27   
 
Yet, the Valencia government has not abandoned the use of private companies to manage public facilities.  
Adeslas has recently been awarded the contract to manage primary care centres in Valencia as well as a new 
contract to manage the Ribera Hospital. 
 
Adeslas is owned by Aguas de Barcelona, the water and waste management company.  In July 2003, Aguas 
de Barcelona sold 25% of its holdings in Adeslas to Mederic, a French insurance company.  It is not yet clear 
what the implications of this change in ownership will be on the distribution of employees in the company.  
Mederic is a French insurance company. 
 
                                                     
24 El Pais 18 November 1999. 
25 El Pais 22 December 2000 
26 El Pais 18 December 2003 Valencia edition „El hospital de Alzira obtuove 25 millones por lucro cesante pese a sus 
elevadas perdidas‟ 
27 Cinco Dias 24 December 2003 „Un informe censura el pago de €25 millions a Adeslas‟ 
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6.2 Company name GENERALE DE SANTE 
 
Owner  
Generale de Sante 
96, avenue d‟Iéna 
75783 Paris Cedex 16 
Tel: +33 (0) 1 53 14 99 
www.generale-de-sante.com 
 
EWC:  ELIGIBLE 
 
Total employees: 17,730 employees with 4,000 independent medical practitioners (2003).   
 
Regional revenues (€ million) 
 
Country 2003 
France €1,033m 
Italy €36.5m 
Canada €15.3m 
 
6.2.1 Major European subsidiaries 
 
Company ownership Country Contact Website 
Compagnie 
Generale de 
Sante 
100% France 96, avenue d‟Iéna 
75783 Paris Cedex 
16 Tel: +33 (0) 1 
53 14 99  
www.generale-
de-sante.fr 
 
Services & 
Sante 
51% France  www.generale-
de-sante.fr 
 
Casa Santa 
Rita 
93.59% Italy Via Manin 29 
51016 
MONTECATINI – 
TERME 
Tel: 00 39 0572 91 
16 88 Fax: 00 39 
0572 92 82 83 
www.generale-
de-sante.fr 
 
Casa Di Cura 
Rugani 
99.50% Italy Piazza Matteotti 33 
53100 SIENNE 
Tel:00 39 0577 26 
16 11 Fax: 00 39 
0577 27 13 43 
www.generale-
de-sante.fr 
 
Centro 
Cardinal 
Farrari 
80% Italy Via IV Novembre, 
n°21 43012 
FONTANELLATO 
Tel: 00 39 (0)521 
82 02 11 Fax: 00 
39 (0)521 82 02 52 
www.generale-
de-sante.fr 
 
Centro 
Diagnostico 
San Nicolo 
(Como) 
51% Italy Via Recchi, 7 
22100 COMO 
Tel:00 39 031 33 
81 170 Fax: 00 39 
031 33 81 122 
www.generale-
de-sante.fr 
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6.2.2 Company activities and strategy 
Generale de Sante is a leading private healthcare company in France with 10% of the market.  The 
company‟s aim is to be “a key player in the private hospital sector in France”. 
 
Generale de Sante provides mental health services, oncology and radiation therapy, sub-acute care (e.g., 
alcohol abuse and obesity treatments) and rehabilitation (cardiac rehabilitation, orthopaedic and neurological 
rehabilitation) services as well as diagnostics (medical imaging and analysis) and home healthcare for elderly 
or disabled people. 
 
Generale de Sante works in partnership with the public hospital sector.  This involves the creation of 
cooperative structures, Public Health Cooperation Associations, dividing their activities between a hospital 
and a clinic located on the same premises, notably in Gassin (Var), Dunkirk (Nord), and Avicenne (Ile-de-
France). 
 
In 2002, it made a strategic decision to withdraw from the nursing home sector because the company felt the 
sector was too crowded, too expensive to develop and achieve a critical mass, and there was a lack of 
synergy between nursing homes and the rest of Generale de Sante work.  The company‟s main focus will 
now be on healthcare. 
 
The company considers that there are increasing transfers of work from the public sector to the private sector 
that Generale de Sante can benefit from.  The private sector is also gaining in market share from the public 
sector.  The company views the increasing social security deficit of the public sector as something that 
together with the introduction of diagnostic related group payment system will enhance the public- private 
transparency from which Generale de Sante will benefit.  
 
In 2003, Generale de Sante main aims were to have 20% of the market share within 5 years, to pursue 
developments in Italy and to increase profitability.  At the end of 2003, the company had sold its Canadian 
residential care homes.  This also involved the removal from the scope of consolidation of two hospital 
investments in Venezuela and Chile.  
 
Generale de Sante was founded by the French water company Generale des Eaux. In 1997, Cinven bought 
the health care interests of Companie Generale des Eaux which were two separate businesses: General 
Health Care and Generale de Sante.  Cinven merged General Health Care with Amicus in December 1997, 
and then sold the merged company to BC Partners.  It continued to develop the Generale de Sante business 
until 2001 when it was floated on the French stock exchange.  The cost of buying General Health Care, 
Amicus and Generale de Sante was €1.77 billion.  The combined value of the sales of these three companies 
was €3.2 billion which was almost double the value of the original investment.  
 
Until June 2003, Cinven has held 44% of the shares of Sante Luxembourg  (Vivendi Universal 20% and 
ABN AMRO and Capital France), which held 38% of General de Sante shares.  There was an agreement 
after flotation in 2000, that Sante Luxembourg would hold shares for three years.  In June 2003, Sante 
Luxembourg shares were sold to Sante Holdings, an Italian holding company owned by Antonino Legresti.  
Sante Holdings is backed by Efibanca, an Italian regional bank.  Sante expects to sell 8% if its share capital 
to Eficanca.  The balance of Sante Luxembourg‟s shares (6.5%) will be placed with French and UK investors 
with no one investor acquiring more than 1.75% shares. 
 
Sante Holdings is chaired by Antonino Legresti, a cardiologist and healthcare entrepreneur who was 
acquitted in 1997 for a fire in a ”iperbarica”  (high compression)  chamber of a clinic in Milan which caused 
the deaths of 11 people.  However a recent Supreme Court ruling annulled his acquittal (17.12.2003). 
 
In December 2003, the Generale de Sante Board of Directors decided to recommend to shareholders that the 
company should adopt a new system of corporate governance which will require changing the articles of 
incorporation.  The new system of corporate governance will involve setting up a Supervisory Board, 
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responsible for management supervision, and a Management Board, responsible for corporate, managerial 
and executive functions.  This change has been precipitated by the change of ownership.  The director of 
Sante Holdings, Antonino Ligresti, will stand for election to the Supervisory Board at the shareholders 
meetings, “with a view to becoming Chairman”.    
 
In 2003, the company introduced a stronger regional structure with greater regional accountability.  It is 
aiming to reduce staff at head quarters by a third which it estimates will generate savings of €4 milllion.   
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6.3 Company name JOSE DE MELLO SAUDE 
 
Owner Grupo Jose de Mello  
José de Mello - SGPS, SA 
Avenida 24 de Julho, 24 
1200-480 Lisboa 
Tel: 21 391 60 00 
Fax: 21 391 61 70 
E-mail: info@josedemello.pt 
www.josedemello.pt 
 
EWC:  No 
 
Total employees:   2,100 
 
6.3.1 Company activities and strategy 
Jose de Mello Saude is part of the De Mello group, a large Portuguese holding company.  The healthcare 
company has 976 beds distributed between three hospitals – Amadora Sintra, CUF Infante Santo and CUF 
Descobertas.   
 
The hospital at Amadora Sintra is a public hospital managed by Jose de Mello Saude.  There have been 
extensive criticisms of the management of hospital by CGTP and regional authorities since the company took 
over the management in 1996.  There has been a lack of transparency between the hospital and the Ministry 
of Health.  Critics of the company point out that the hospital expenditure was far greater than for other 
publicly managed hospitals. The Inspector General of Finances has investigated some of the complaints 
against the hospital by the trade unions and regional health administration.  These included the Jose de Mello 
Saude company using the facilities of the public hospital in Sintra for private patients.  Doctors had set up 
their own surgical company and rented space from the hospital.  In other cases, doctors have seen private 
patients during public clinics. 28 (www.sic.pt).  There have been demands for a Parliamentary inquiry.  The 
current health minister is a former employee of Jose de Mello Saude. 
 
In 2000, the company set up, together with ICATU (a private group in Brazil that operates in the financial, 
property, insurance, entertainment and healthcare sectors) and the International Finance Corporation, a 
company called ICATU health services which works in homecare, hospital management and health 
insurance. 
 
Jose de Mello Saude aims to look for growth opportunities in selected international markets.  It is currently 
in discussion with Associacao Nacional de Farmacias (Portugal), Generale de Sante (France), ICATU 
(Brazil) and IFC about strategic projects.  29  
                                                     
28 http://sic.sapo.pt/article23965visual4.html 
29  www.josedemellosaude.pt 
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6.4  Company name MARSEILLE-KLINIKEN 
 
Owner  
Marseille Kliniken 
Sportallee 1 
D-22335 Hamburg, Germany  
Phone: 49 40 5 14 59 0 
Fax: 49 40 5 14 59 709  
www.marseille-kliniken.de 
 
EWC:  No 
 
Total employees:  4,122 
 
6.4.1 Company activities and strategy 
 
Marseille -Kliniken-AG, founded in 1984 by Theo and Ulrich Marseille, runs retirement homes, 
rehabilitation homes and special geriatric hospitals mainly in Germany with expansion since 1992 into 
eastern Germany.  It expanded into the rehabilitation sector in 1996 by buying KASANAG and its subsidiary 
companies and is now the largest provider of private nursing care and the third largest clinic operator in 
Germany. The company also operates the AMARITA franchise system set up in 2000 to provide nursing 
care.  The company builds nursing homes and then sells the buildings. The company plans to fund future 
growth through the sale of its own properties and sale of AMARITA nursing homes.  It aims to move from 
70% property owned, 30% rented to 30% owned and 70% rented.   This is another example of a healthcare 
company selling properties to release capital (e.g.Capio). 
 
The strategy of the company is to reduce the stock of company owned beds and release resources through the 
sale of existing property and new buildings, e.g. AMATITA nursing homes.  In nursing, it plans to acquire 
facilities from public providers, build new facilities and create a national presence.  In Rehabilitation the 
company aims to work cooperatively with acute care facilities, to extend the range of services but not to 
extent capacity.  
 
In the period 1999-2003 there have been changes in the composition of the workforce which is made up of 
2,105 employees in Nursing, 790 employees in rehabilitation and 1,227 employees in services.  In both 
nursing and rehabilitation, there has been a slight decrease in housekeeping staff. 
 
75% of shares are owned by the Marseille family and of the remaining shares, 50% are individually owned 
and 50% institutionally owned. 
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6.5 Company name PARACELSUS KLINIKEN 
 
Owner  
Paracelsus Kliniken 
Paracelsus hospitals - Germany GmbH 
Klinsorstr. 5 
81927 Munich 
Germany  
www.paracelsus-kliniken.de 
 
EWC:  No 
 
Total employees:  4,500  
 
6.5.1 Company activities and strategy 
Paracelsus- Kliniken Deutschland GmbH runs 16 acute hospitals and 12 rehabilitation centres in Germany 
and one hospital in Switzerland.  The hospital group was founded by Prof.Dr.Kruckemayer and opened in 
1970.  It introduced a model of integrated primary and secondary care.  Doctors run their own practices from 
hospital premises. Equipment is shared by different departments.  These principles still inform the company. 
 
Paracelusus-Klinken expanded in the 1980s.  In 1996 the company acquired Champion Healthcare 
Corporation, an American healthcare company.  The following year, following the death of its founder, 
Paracelsus- Kliniken Deutschland GmbH was formed and appears to have remained separate from the 
Paracelsus Healthcare company in the US.  Paracelsus (US) filed for bankruptcy in 2000 and was also 
accused of Medicare fraud.  In 2001 it re-emerged as the Clarent Hospital Corporation.     
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6.6 Company name RHOEN-KLINIKUM AG 
 
Owner  
Rhoen-Klinikum 
Salzburger Leite 1 
97616 Bad Neustadt/Saale,  
Germany 
Tel: +49 9771-65-0 
Fax: +49 9771-97467 
www.rhoen-klinikum-ag.com 
 
EWC:  No 
 
Total employees:   13,436 
 
6.6.1 Company activities and strategy 
The Rhoen Klinikum Group operates acute hospitals (96% revenue), rehabilitation clinics and outpatient 
clinics.  All the acute hospitals are either included in state planning or have service contracts with health 
insurance funds.  In 2002 it acquired 6 hospitals, of which 3 were district general hospitals.  In the first 9 
months of 2003, it bought 3 hospitals, all in Germany. In 2003, an investment in South Africa had to be 
abandoned because of the resources that would have been required.  The company also registered an interest 
in buying some of the Generale de Sante shares in early 2003 although it did not make a bid.  These two 
actions may be seen as an indication that the company is interested in expanding although is also cautious 
about future international commitments. 
 
The workforce has expanded from 12,852 employees in 2002 to 13,436 in 2003, mainly as a result of buying 
the Cuxhaven hospital. Over 66% of employees are nursing staff.  Rhoen Klinikum runs its own school of 
nursing. 
 
Until recently the major investor was the von Guttenberg family which has been a shareholder since 1970.  
24% of shares are now held by the Munch family and 27% by HVB. 
 
 
 
 
